Hormone therapy in perimenopause vs after menopause

Hormone therapy uses the same hormones before and after your final period, but the situation it is treating is different. In perimenopause your ovaries still produce estrogen in unpredictable surges and dips, you may still ovulate and can still conceive, and you will still bleed, so regimens are built around your own cycle and the therapy does not replace contraception. After menopause your own production has stopped, continuous regimens that avoid bleeding become standard, and the well-studied framework of starting under 60 or within 10 years of menopause applies.

Where the line is

The Stages of Reproductive Aging Workshop (STRAW+10) defines the stages by menstrual pattern. The menopausal transition begins when cycle length starts to vary persistently and ends at the final menstrual period. Perimenopause includes that transition plus the first year afterward; menopause is confirmed only after 12 months without a period. The National Institute on Aging puts the average age at menopause in the United States at 52, with the transition usually beginning between 45 and 55, and says symptoms last between 2 and 8 years for most women.

A 2021 review in the Journal of Clinical Endocrinology and Metabolism estimates the median transition at about 4 years and describes it as a time of wide hormonal fluctuation and irregular cycles. For what is happening and how to recognize it, start with what is perimenopause.

Why perimenopause is different for treatment

Your hormones are not low, they are erratic. Estradiol levels in perimenopause tend to be higher and more variable than after menopause, with swings that trigger hot flashes, sore breasts, heavy bleeding, and mood changes. Adding a fixed dose of estrogen does not switch off that background activity, and standard menopausal doses do not reliably suppress your own hormone production.

You can still get pregnant. Fertility declines but does not end until menopause is confirmed. Menopausal hormone therapy is not a contraceptive. The National Institute on Aging advises using birth control until a full 12 months after your last period.

You will bleed. Your own cycles continue, and any progestogen you add shapes the pattern. Expect bleeding and plan for it rather than being alarmed by it, but know which bleeding needs evaluation (below).

The evidence is thinner. The Women’s Health Initiative enrolled postmenopausal women only. The 2017 Cochrane review of long-term hormone therapy found that none of its 22 trials focused on perimenopausal women and that data were insufficient to assess long-term use in that group. The Menopause Society’s 2022 statement says the same. None of this suggests harm; it means clinicians extrapolate from women a few years older.

Regimens in perimenopause

Approach	How it works	Bleeding	Notes
Estrogen daily plus cyclic progesterone	Estradiol patch, gel, or pill every day; micronized progesterone 200 mg at bedtime for 12 to 14 days each month	Predictable monthly withdrawal bleed	Mirrors a natural cycle; the regimen most often used while periods continue
Estrogen daily plus levonorgestrel IUD	The IUD supplies the progestogen locally; estrogen treats symptoms	Often lighter or absent	Off-label for endometrial protection per The Menopause Society; also provides contraception
Continuous estrogen plus daily progestogen	Both every day	Irregular spotting is common while you still cycle	Usually reserved for after periods have stopped
Progesterone alone at bedtime	300 mg nightly, off-label	Your own cycles continue	Tested in a 2023 trial; see below

Doses are the same as after menopause. Details are in our guides to the estrogen patch and micronized progesterone.

What the perimenopause trials show

Hormone therapy’s effect on hot flashes is well established in postmenopausal women; see what is hormone therapy. Trials restricted to perimenopausal women are few and small.

The largest is a 2023 Canadian randomized trial of 189 perimenopausal women aged 35 to 58 who took oral micronized progesterone 300 mg at bedtime or placebo for 3 months. The primary outcome, a combined hot flash and night sweat score, did not differ significantly (a difference of 1.5 points, P = 0.22), though the trial was underpowered and could not exclude a clinically meaningful benefit. Women on progesterone did report fewer night sweats (P = 0.023), better sleep quality (P = 0.005), and less interference with daily life, with no serious adverse events. The authors noted that the two earlier estrogen-based trials confined to perimenopausal women were also small and inconclusive.

The practical reading: progesterone alone is a reasonable option for perimenopausal night sweats and sleep when estrogen is unwanted or not yet needed, and estrogen-based therapy is used on the strength of postmenopausal evidence plus the low baseline risks of women in their 40s.

After menopause: the standard framework

Once 12 months have passed without a period, the question becomes the familiar one. The Menopause Society’s 2022 position: for women under 60 or within 10 years of menopause with bothersome symptoms and no contraindications, benefits outweigh risks; starting later is less favorable because baseline risks of heart disease, stroke, clots, and dementia are higher. Continuous-combined regimens, estrogen plus a daily progestogen, become standard because they usually stop bleeding. Our guide Is hormone therapy safe? covers the numbers.

Women who start in perimenopause simply carry on. The regimen is often switched from cyclic to continuous once periods have stopped for a year, and the progestogen can be dropped only if the uterus has been removed.

Side by side

	Perimenopause	After menopause
Own estrogen production	Erratic, sometimes high	Low and stable
Pregnancy possible	Yes, until 12 months without a period	No
Typical regimen	Cyclic progestogen or hormonal IUD with estrogen	Continuous-combined, or estrogen alone after hysterectomy
Expected bleeding	Yes; monthly withdrawal bleed on cyclic regimens	Usually none after the first months
Randomized evidence	Sparse; trials small and underpowered	Extensive (WHI and others)
Safety window	Not separately defined; low baseline risk at these ages	Under 60 or within 10 years of menopause

Bleeding that needs evaluation

Changes in bleeding are normal in perimenopause, but some patterns need a visit. The National Institute on Aging lists bleeding or spotting after sex or between periods, and bleeding that starts again after more than a year without a period. The Menopause Society adds that on combined hormone therapy, unscheduled bleeding that continues more than 6 months after starting should be investigated. Evaluation is usually an ultrasound and sometimes an endometrial biopsy.

Questions to ask

• Am I in perimenopause or past menopause, and how does that change your recommendation?
• Do I still need contraception, and would a hormonal IUD cover both needs?
• Cyclic or continuous progestogen, and what bleeding should I expect?
• Would progesterone alone be worth trying first for my night sweats?
• When should I call about bleeding?

If your clinician is not comfortable prescribing in perimenopause, our guide to finding a menopause specialist explains who has focused training, and our OB-GYN directory lists clinicians by city.